These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 16553530)
1. Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine. Apter A; Lipschitz A; Fong R; Carpenter DJ; Krulewicz S; Davies JT; Wilkinson C; Perera P; Metz A J Child Adolesc Psychopharmacol; 2006; 16(1-2):77-90. PubMed ID: 16553530 [TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials. Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354 [TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of suicidality in patients treated with the antidepressant desvenlafaxine. Tourian KA; Padmanabhan K; Groark J; Ninan PT J Clin Psychopharmacol; 2010 Aug; 30(4):411-6. PubMed ID: 20631558 [TBL] [Abstract][Full Text] [Related]
4. Clinical features of patients with treatment-emergent suicidal behavior following initiation of paroxetine therapy. Kraus JE; Horrigan JP; Carpenter DJ; Fong R; Barrett PS; Davies JT J Affect Disord; 2010 Jan; 120(1-3):40-7. PubMed ID: 19439363 [TBL] [Abstract][Full Text] [Related]
5. Citalopram and suicidality in adult major depression and anxiety disorders. Pedersen AG Nord J Psychiatry; 2006; 60(5):392-9. PubMed ID: 17038305 [TBL] [Abstract][Full Text] [Related]
6. Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis. Mosholder AD; Willy M J Child Adolesc Psychopharmacol; 2006; 16(1-2):25-32. PubMed ID: 16553526 [TBL] [Abstract][Full Text] [Related]
7. Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents. March JS; Klee BJ; Kremer CM J Child Adolesc Psychopharmacol; 2006; 16(1-2):91-102. PubMed ID: 16553531 [TBL] [Abstract][Full Text] [Related]
8. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
9. Maternal suicidality and risk of suicidality in offspring: findings from a community study. Lieb R; Bronisch T; Höfler M; Schreier A; Wittchen HU Am J Psychiatry; 2005 Sep; 162(9):1665-71. PubMed ID: 16135626 [TBL] [Abstract][Full Text] [Related]
10. Escitalopram therapy for major depression and anxiety disorders. Baldwin DS; Reines EH; Guiton C; Weiller E Ann Pharmacother; 2007 Oct; 41(10):1583-92. PubMed ID: 17848424 [TBL] [Abstract][Full Text] [Related]
11. An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder. Berard R; Fong R; Carpenter DJ; Thomason C; Wilkinson C J Child Adolesc Psychopharmacol; 2006; 16(1-2):59-75. PubMed ID: 16553529 [TBL] [Abstract][Full Text] [Related]
12. Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression. Verkes RJ; Van der Mast RC; Hengeveld MW; Tuyl JP; Zwinderman AH; Van Kempen GM Am J Psychiatry; 1998 Apr; 155(4):543-7. PubMed ID: 9546002 [TBL] [Abstract][Full Text] [Related]
13. Specific depressive symptoms and disorders as associates and predictors of suicidal acts across adolescence. Nrugham L; Larsson B; Sund AM J Affect Disord; 2008 Nov; 111(1):83-93. PubMed ID: 18395267 [TBL] [Abstract][Full Text] [Related]
14. Suicidality and psychopathology in hospitalized children and adolescents. Borst SR; Noam GG Acta Paedopsychiatr; 1989; 52(3):165-75. PubMed ID: 2487488 [TBL] [Abstract][Full Text] [Related]
15. Suicide rates in short-term randomized controlled trials of newer antidepressants. Hammad TA; Laughren TP; Racoosin JA J Clin Psychopharmacol; 2006 Apr; 26(2):203-7. PubMed ID: 16633153 [TBL] [Abstract][Full Text] [Related]
16. Lack of association between fluoxetine and suicidality in bulimia nervosa. Wheadon DE; Rampey AH; Thompson VL; Potvin JH; Masica DN; Beasley CM J Clin Psychiatry; 1992 Jul; 53(7):235-41. PubMed ID: 1639742 [TBL] [Abstract][Full Text] [Related]
17. Psychopathology associated with suicidal ideation and attempts among children and adolescents. Gould MS; King R; Greenwald S; Fisher P; Schwab-Stone M; Kramer R; Flisher AJ; Goodman S; Canino G; Shaffer D J Am Acad Child Adolesc Psychiatry; 1998 Sep; 37(9):915-23. PubMed ID: 9735611 [TBL] [Abstract][Full Text] [Related]
18. Antidepressants use in children and adolescents and the risk of suicide. Wohlfarth TD; van Zwieten BJ; Lekkerkerker FJ; Gispen-de Wied CC; Ruis JR; Elferink AJ; Storosum JG Eur Neuropsychopharmacol; 2006 Feb; 16(2):79-83. PubMed ID: 16298514 [TBL] [Abstract][Full Text] [Related]
19. Occurrence and course of suicidality during short-term treatment of late-life depression. Szanto K; Mulsant BH; Houck P; Dew MA; Reynolds CF Arch Gen Psychiatry; 2003 Jun; 60(6):610-7. PubMed ID: 12796224 [TBL] [Abstract][Full Text] [Related]
20. Nicotine dependence is associated with suicide attempts and self-mutilation among adolescent females. Riala K; Hakko H; Räsänen P; Compr Psychiatry; 2009; 50(4):293-8. PubMed ID: 19486726 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]